These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 8711485

  • 1. Possibilities of brain protection with tirilazad after cardiac arrest.
    Sterz F, Janata K, Kürkciyan I, Müllner M, Malzer R, Schreiber W.
    Semin Thromb Hemost; 1996; 22(1):105-12. PubMed ID: 8711485
    [Abstract] [Full Text] [Related]

  • 2. Amelioration of impaired cerebral metabolism after severe acidotic ischemia by tirilazad posttreatment in dogs.
    Kim H, Koehler RC, Hurn PD, Hall ED, Traystman RJ.
    Stroke; 1996 Jan; 27(1):114-21. PubMed ID: 8553386
    [Abstract] [Full Text] [Related]

  • 3. Effects of the 21-amino steroid tirilazad mesylate (U-74006F) on brain damage and edema after perinatal hypoxia-ischemia in the rat.
    Bågenholm R, Andiné P, Hagberg H.
    Pediatr Res; 1996 Sep; 40(3):399-403. PubMed ID: 8865275
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of lipid peroxidation in central nervous system trauma and ischemia.
    Hall ED.
    J Neurol Sci; 1995 Dec; 134 Suppl():79-83. PubMed ID: 8847548
    [Abstract] [Full Text] [Related]

  • 5. Lazaroids: efficacy and mechanism of action of the 21-aminosteroids in neuroprotection.
    Kavanagh RJ, Kam PC.
    Br J Anaesth; 2001 Jan; 86(1):110-9. PubMed ID: 11575384
    [No Abstract] [Full Text] [Related]

  • 6. Pyrrolopyrimidines: novel brain-penetrating antioxidants with neuroprotective activity in brain injury and ischemia models.
    Hall ED, Andrus PK, Smith SL, Fleck TJ, Scherch HM, Lutzke BS, Sawada GA, Althaus JS, Vonvoigtlander PF, Padbury GE, Larson PG, Palmer JR, Bundy GL.
    J Pharmacol Exp Ther; 1997 May; 281(2):895-904. PubMed ID: 9152399
    [Abstract] [Full Text] [Related]

  • 7. [Tirilazad mesylate (Freedox)--an effective inhibitor of lipid membrane peroxidation].
    Sániová B.
    Bratisl Lek Listy; 1997 Jun; 98(6):339-42. PubMed ID: 9333426
    [Abstract] [Full Text] [Related]

  • 8. Prevention, treatment, and resuscitation of cerebral ischemia.
    Illievich UM, Dumitrescu RV, Papousek A, Schreier H, Glaser C, Klimscha W.
    Acta Anaesthesiol Scand Suppl; 1997 Jun; 111():95-9. PubMed ID: 9420970
    [No Abstract] [Full Text] [Related]

  • 9. Efficacy and mechanisms of action of the cytoprotective lipid peroxidation inhibitor tirilazad mesylate in subarachnoid haemorrhage.
    Hall ED.
    Eur J Anaesthesiol; 1996 May; 13(3):279-89. PubMed ID: 8737119
    [Abstract] [Full Text] [Related]

  • 10. [Cerebral protection].
    Cattaneo AD.
    Minerva Anestesiol; 1993 Sep; 59(9):403-17. PubMed ID: 8278062
    [Abstract] [Full Text] [Related]

  • 11. Effects of nalmefene, CG3703, tirilazad, or dopamine on cerebral blood flow, oxygen delivery, and electroencephalographic activity after traumatic brain injury and hemorrhage.
    Dewitt DS, Prough DS, Uchida T, Deal DD, Vines SM.
    J Neurotrauma; 1997 Dec; 14(12):931-41. PubMed ID: 9475374
    [Abstract] [Full Text] [Related]

  • 12. Randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in Europe, Australia, and New Zealand.
    Kassell NF, Haley EC, Apperson-Hansen C, Alves WM.
    J Neurosurg; 1996 Feb; 84(2):221-8. PubMed ID: 8592224
    [Abstract] [Full Text] [Related]

  • 13. Effect of 21-aminosteroid lipid peroxidation inhibitor, U74006F, in the rat middle cerebral artery occlusion model.
    Umemura K, Wada K, Uematsu T, Mizuno A, Nakashima M.
    Eur J Pharmacol; 1994 Jan 04; 251(1):69-74. PubMed ID: 8137871
    [Abstract] [Full Text] [Related]

  • 14. Lazaroids. CNS pharmacology and current research.
    Clark WM, Hazel JS, Coull BM.
    Drugs; 1995 Dec 04; 50(6):971-83. PubMed ID: 8612475
    [Abstract] [Full Text] [Related]

  • 15. Neuroprotective efficacy of microvascularly-localized versus brain-penetrating antioxidants.
    Hall ED, Andrus PK, Smith SL, Oostveen JA, Scherch HM, Lutzke BS, Raub TJ, Sawada GA, Palmer JR, Banitt LS, Tustin JS, Belonga KL, Ayer DE, Bundy GL.
    Acta Neurochir Suppl; 1996 Dec 04; 66():107-13. PubMed ID: 8780807
    [Abstract] [Full Text] [Related]

  • 16. Tirilazad pretreatment improves early cerebral metabolic and blood flow recovery from hyperglycemic ischemia.
    Maruki Y, Koehler RC, Kirsch JR, Blizzard KK, Traystman RJ.
    J Cereb Blood Flow Metab; 1995 Jan 04; 15(1):88-96. PubMed ID: 7798342
    [Abstract] [Full Text] [Related]

  • 17. [The therapeutic potential of lazaroids (21-aminosteroids). A recent survey].
    Buttgereit F, Hiepe F, Burmester GR.
    Dtsch Med Wochenschr; 1997 Oct 31; 122(44):1363-7. PubMed ID: 9410710
    [No Abstract] [Full Text] [Related]

  • 18. Protective effects of tirilazad mesylate and metabolite U-89678 against blood-brain barrier damage after subarachnoid hemorrhage and lipid peroxidative neuronal injury.
    Smith SL, Scherch HM, Hall ED.
    J Neurosurg; 1996 Feb 31; 84(2):229-33. PubMed ID: 8592225
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of microglial activation contributes to propofol-induced protection against post-cardiac arrest brain injury in rats.
    Wang W, Lu R, Feng DY, Liang LR, Liu B, Zhang H.
    J Neurochem; 2015 Sep 31; 134(5):892-903. PubMed ID: 26016627
    [Abstract] [Full Text] [Related]

  • 20. The effect of tirilazad mesylate (U74006F) on cerebral oxygen consumption, and reactivity of cerebral blood flow to carbon dioxide in healthy volunteers.
    Olsen KS, Videbaek C, Agerlin N, Krøll M, Bøge-Rasmussen T, Paulson OB, Gjerris F.
    Anesthesiology; 1993 Oct 31; 79(4):666-71. PubMed ID: 8214745
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.